178 related articles for article (PubMed ID: 35057866)
1. Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis.
Li X; Jia Q; Zhou Y; Jiang X; Song L; Wu Y; Wang A; Chen W; Wang S; Lu Y
Exp Hematol Oncol; 2022 Jan; 11(1):2. PubMed ID: 35057866
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Tanshinone IIA-mediated inhibition on miR-125b/STARD13 axis attenuates the stemness and enhances adriamycin sensitivity of breast cancer cells.
Li X; Zheng L; Xi T
Biochimie; 2019 May; ():. PubMed ID: 31078586
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis.
Ni H; Ruan G; Sun C; Yang X; Miao Z; Li J; Chen Y; Qin H; Liu Y; Zheng L; Xing Y; Xi T; Li X
Environ Toxicol; 2022 Feb; 37(2):192-200. PubMed ID: 34661962
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
Tang F; Zhang R; He Y; Zou M; Guo L; Xi T
PLoS One; 2012; 7(5):e35435. PubMed ID: 22693547
[TBL] [Abstract][Full Text] [Related]
5. MiR-125b enhances doxorubicin-induced cardiotoxicity by suppressing the nucleus-cytoplasmic translocation of YAP via targeting STARD13.
Jin X; Yu W; Ye P
Environ Toxicol; 2022 Apr; 37(4):730-740. PubMed ID: 34921586
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.
Qin J; Shi H; Xu Y; Zhao F; Wang Q
Biomed Pharmacother; 2018 Sep; 105():758-765. PubMed ID: 29909343
[TBL] [Abstract][Full Text] [Related]
7. STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.
Gao F; Yu X; Meng R; Wang J; Jia L
Onco Targets Ther; 2018; 11():5371-5381. PubMed ID: 30214243
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA attenuates high glucose induced human VSMC proliferation and migration through miR-21-5p-mediated tropomyosin 1 downregulation.
Jia S; Ma WD; Zhang CY; Zhang Y; Yao ZH; Quan XH; Guo X; Wang CX
Arch Biochem Biophys; 2019 Nov; 677():108154. PubMed ID: 31672498
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.
Hu R; Zhu X; Chen C; Xu R; Li Y; Xu W
Cell Prolif; 2018 Dec; 51(6):e12508. PubMed ID: 30084199
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA improves miR-133 expression through MAPK ERK1/2 pathway in hypoxic cardiac myocytes.
Zhang L; Wu Y; Li Y; Xu C; Li X; Zhu D; Zhang Y; Xing S; Wang H; Zhang Z; Shan H
Cell Physiol Biochem; 2012; 30(4):843-52. PubMed ID: 22890296
[TBL] [Abstract][Full Text] [Related]
11. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
14. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L
EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Factor Yin Yang 1 Promotes the Stemness of Breast Cancer Cells by Suppressing miR-873-5p Transcriptional Activity.
Guo Q; Wang T; Yang Y; Gao L; Zhao Q; Zhang W; Xi T; Zheng L
Mol Ther Nucleic Acids; 2020 Sep; 21():527-541. PubMed ID: 32711380
[TBL] [Abstract][Full Text] [Related]
16. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
Lu Q; Zhang P; Zhang X; Chen J
Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.
Chang S; He S; Qiu G; Lu J; Wang J; Liu J; Fan L; Zhao W; Che X
Tumour Biol; 2016 Sep; 37(9):12141-12151. PubMed ID: 27220320
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling.
You K; Li SY; Gong J; Fang JH; Zhang C; Zhang M; Yuan Y; Yang J; Zhuang SM
Mol Ther Nucleic Acids; 2018 Sep; 12():57-66. PubMed ID: 30195793
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA regulates human AML cell proliferation, cell cycle, and apoptosis through miR-497-5p/AKT3 axis.
Nie ZY; Zhao MH; Cheng BQ; Pan RF; Wang TR; Qin Y; Zhang XJ
Cancer Cell Int; 2020; 20():379. PubMed ID: 32782437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
